New AIDS vaccine effort urged

IAVI poised to create a consortium to study live attenuated AIDS vaccine in monkeys

Written byRobert Walgate
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

BANGKOK—Only a vaccine can end the AIDS epidemic, but the effort to develop one so far has been disgraceful, Seth Berkley, president of the International AIDS Vaccine Initiative (IAVI), said here at the International AIDS Conference.

"We've had one candidate fully tested in humans," he told reporters at the meeting. "That is a global disgrace."

Berkley said the world needs to make vaccines part of the comprehensive agenda against AIDS. "We need an enhanced science effort, using an industrial model," he told The Scientist. Candidates need to be developed in parallel and not sequentially, and "we must solve the remaining scientific challenges that are holding us back."

The number of vaccine candidates in the pipeline is now about 30. The trouble is, all the candidates seem to be working on a single approach, T-cell immunity, said Wayne Koff, IAVI's senior vice president for research.

Crucially, scientists have known for over ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies